Table 5 Changes in BMI measurements and laboratory results in children treated with anti-obesity medications (AOMs)- all AOMs and by medication type.

From: Real -world experience with anti-obesity medications treatment in children and adolescents with overweight and obesity in Israel

 

Last measurement before first drug purchase

Minimal measurement during treatment period*

Last measurement before end of treatment

First measurement after end of treatment

P time

P sex

P time×sex

All AOMs

BMI-Z Score

       

Males

3.15 (0.05) a

2.63 (0.04) b

2.93 (0.04) c

2.87 (0.06) c

<0.001

<0.001

0.987

Females

2.98 (0.05) a

2.47 (0.03) b

2.76 (0.03) c

2.73 (0.04) c

<0.001

  

Fasting blood glucose(mg/dL)

Males

140.8 (3.3) a

96.4 (2.8) b

126.4 (4.2) c

115.8 (3.5) d

<0.001

<0.001

0.384

Females

128.6 (2.6) a

92.2 (1.8) b

115.6 (2.8) c

109.2 (2.3) c

<0.001

  

HbA1c (%)

Males

6.8 (0.10) a

5.8 (0.08) b

6.3 (0.08) c

6.5 (0.16) a,c

<0.001

<0.001

0.266

Females

6.4 (0.07) a

5.6 (0.05) b

5.9 (0.05) c

6.0 (0.10) c

<0.001

  

Triglycerides (mg/dL)

Males

153.7 (5.7) a

99.9 (4.4) b

141.7 (8.1) a

141.8 (8.0) a

<0.001

0.745

0.511

Females

152.5 (4.2) a

106.9 (3.2) b

135.6 (5.8) c

135.7 (5.9) c

<0.001

  

HDL- Cholesterol (mg/dL)

Males

42.0 (0.6) a

48.0 (0.5) b

42.2 (0.7) a,c

43.8 (0.5) c

<0.001

0.686

0.227

Females

42.1 (0.5) a

47.0 (0.4) b

43.2 (0.5) a,c

44.2 (0.4) c

<0.001

  

LDL-cholesterol (mg/dL)

Males

96.3 (1.4)

92.1 (2.0)

95.3 (1.6)

93.3 (2.0)

0.298

0.659

0.758

Females

97.9 (1.3)

93.3 (1.6)

93.9 (1.5)

94.2 (1.6)

0.065

  

Total cholesterol (mg/dL)

Males

167.6 (1.9) a

150.8 (1.5) b

164.3 (2.1) a

165.9 (2.6) a

<0.001

0.321

0.996

Females

168.6 (1.4) a

152.5 (1.1) b

165.4 (1.6) a

167.3 (2.0) a

<0.001

  

ALT (U/L)

Males

33.0 (1.4)

30.0 (1.8)

29.5 (1.5)

29.7 (1.9)

0.286

0.012

0.996

Females

36.0 (1.2)

33.1 (1.5)

31.9 (1.4)

32.3 (1.6)

0.087

  

Metformin (n = 1 267)

BMI-Z Score

Males

2.98 (0.07) a

2.46 (0.05) b

2.81 (0.05) c

2.68 (0.07) c

<0.001

0.002

0.965

Females

2.83 (0.06) a

2.34 (0.04) b

2.68 (0.04) c

2.59 (0.05) c

<0.001

  

Fasting blood glucose(mg/dL)

Males

153.4 (4.1) a

101.0 (3.6) b

135.2 (5.0) c

126.1 (4.5) c

<0.001

<0.001

0.322

Females

136.4 (2.7) a

95.1 (2.3) b

121.7 (3.3) c

115.6 (2.8) c

<0.001

  

HbA1c (%)

Males

6.7 (0.13) a

5.8 (0.10) b

6.3 (0.10) c

6.5 (0.20) ac

<0.001

<0.001

0.385

Females

6.5 (0.08) a

5.6 (0.06) b

5.9 (0.06) c

5.9 (0.11) c

<0.001

  

Triglycerides (mg/dL)

Males

159.6 (7.6) a

101.6 (5.8) b

144.1 (11.0) a

144.4 (11.2) a

<0.001

0.413

0.614

Females

156.3 (5.2) a

106.8 (4.0) b

134.2 (7.1) c

134.7 (7.3) c

<0.001

  

HDL- Cholesterol (mg/dL)

Males

41.5 (0.7) a

47.0 (0.5) b

42.2 (0.8) a

43.0 (0.6) a

<0.001

0.125

0.438

Females

42.1 (0.5) a

46.7 (0.4) b

43.4 (0.6) a,c

44.1 (0.5) c

<0.001

  

LDL-cholesterol (mg/dL)

Males

94.9 (1.7)

92.8 (2.6)

94.5 (1.9)

93.9 (2.6)

0.920

0.539

0.735

Females

98.2 (1.5)

93.1 (1.9)

94.3 (1.7)

94.1 (1.9)

0.114

  

Total cholesterol (mg/dL)

Males

166.4 (2.4) a

150.7 (1.8) b

164.0 (3.5) a

164.3 (3.5) a

<0.001

0.178

0.987

Females

169.0 (1.6) a

152.1 (1.2) b

165.6 (1.9) a

166.9 (2.2) a

<0.001

  

ALT (U/L)

Males

32.2 (1.6)

30.1 (2.2)

27.9 (1.8)

29.4 (2.2)

0.336

0.008

0.999

Females

35.9 (1.4)

33.3 (1.7)

31.4 (1.6)

33.1 (1.9)

0.190

  

GLP-1 receptor agonist (n = 420)

BMI-Z Score

Males

3.45 (0.05) a

3.08 (0.05) b

3.22 (0.05) c

3.31 (0.06) ac

<0.001

<0.001

0.978

Females

3.28 (0.05) a

2.95 (0.05) b

3.06 (0.05) c

3.16 (0.06) ac

<0.001

  

Fasting blood glucose(mg/dL)

Males

92.8 (1.3) a

82.4 (1.0) b

86.8 (1.7) c

87.4 (1.2) c

<0.001

0.876

0.972

Females

93.1 (1.3) a

82.2 (1.2) b

86.4 (2.1) b,c

88.4 (1.5) c

<0.001

  

HbA1c (%)

Males

6.9 (0.17) a

5.7 (0.14) b

6.2 (0.14) c

6.5 (0.24) a,c

<0.001

0.010

0.254

Females

6.3 (0.14) a

5.6 (0.11) b

5.9 (0.10) c

6.4 (0.21) a

<0.001

  

Triglycerides (mg/dL)

Males

136.0 (7.6) a

95.8 (6.1) b

135.2 (10.0) a

135.3 (10.1) a

<0.001

0.123

0.983

Females

144.0 (6.3) a

107.8 (4.9) b

142.2 (9.0) a

142.9 (9.1) a

<0.001

  

HDL- Cholesterol (mg/dL)

Males

42.8 (1.2) a

50.4 (0.9) b

42.4 (1.4) a

45.5 (1.0) a

<0.001

0.181

0.768

Females

41.8 (1.1) a

48.2 (0.8) b

42.4 (1.2) a

44.5 (1.0) a

<0.001

  

LDL-cholesterol (mg/dL)

Males

99.6 (2.3)

92.1 (3.1)

98.4 (2.8)

93.3 (3.1)

0.154

0.861

0.464

Females

97.1 (2.7)

95.5 (3.6)

93.2 (3.2)

96.0 (3.6)

0.818

  

Total cholesterol (mg/dL)

Males

170.1 (2.9) a

151.5 (2.3) b

166.5 (3.5) a

168.3 (3.8) a

<0.001

0.812

0.803

Females

167.8 (3.1) a

154.3 (2.4) b

165.9 (3.6) a

170.6 (4.5) a

<0.001

  

ALT (U/L)

Males

35.2 (2.8)

30.0 (3.5)

33.9 (3.2)

30.1 (3.5)

0.549

0.684

0.952

Females

37.3 (2.5)

32.0 (3.2)

33.0 (2.9)

30.5 (3.5)

0.355

  

Orlistat (n = 30)

BMI-Z Score

Males

3.37 (0.57)

2.63 (0.45)

3.24 (0.45)

2.31 (0.52)

0.452

0.023

0.402

Females

2.42 (0.37)

1.93 (0.21)

2.32 (0.21)

2.48 (0.26)

0.323

  

Fasting blood glucose(mg/dL)

Males

88.0 (4.4)

82.0 (3.1)

91.0 (5.0)

90.9 (3.3)

0.232

0.249

0.848

Females

85.2 (3.7)

81.1 (2.5)

82.7 (4.5)

89.3 (2.8)

0.187

  

HbA1c (%)

Males

7.7 (1.1)

5.6 (0.9)

5.9 (0.9)

7.5 (1.6)

0.424

0.043

0.354

Females

6.1 (0.4)

5.6 (0.4)

5.6 (0.3)

5.3 (0.6)

0.692

  

Triglycerides (mg/dL)

Males

163.8 (41.2)

99.6 (38.1)

162.7 (50.0)

162.8 (50.4)

0.612

0.014

0.402

Females

107.2 (15.4)

99.9 (12.2)

85.0 (21.2)

85.5 (21.8)

0.780

  

HDL- Cholesterol (mg/dL)

Males

46.5 (5.2)

47.0 (4.8)

32.5 (9.1)

43.3 (6.4)

0.547

0.411

0.657

Females

45.1 (3.1)

47.6 (2.5)

44.0 (4.0)

43.5 (3.1)

0.740

  

LDL-cholesterol (mg/dL)

Males

98.8 (13.8)

81.4 (15.1)

68.5 (23.9)

81.4 (15.1)

0.669

0.886

0.839

Females

100.2 (7.7)

74.8 (10.4)

85.6 (9.4)

74.8 (10.4)

0.164

  

Total cholesterol (mg/dL)

Males

171.4 (17.2)

145.0 (16.0)

118.0 (29.9)

174.7 (21.1)

0.336

0.721

0.338

Females

161.0 (8.2)

143.3 (6.6)

147.5 (10.3)

142.8 (12.2)

0.380

  

ALT (U/L)

Males

26.3 (7.6)

28.8 (8.3)

20.5 (13.1)

30.3 (9.3)

0.934

0.530

0.740

Females

29.2 (6.7)

37.1 (9.1)

36.3 (8.1)

21.6 (10.8)

0.643

  
  1. *For HDL-cholesterol—maximal measurement during treatment period Mixed models repeated measures analysis. Values are presented as estimated means and standard error (SE). Variables with different superscripts (a, b, c, d) significantly differ from each other at p < 0.05 at post hoc least significant difference pairwise comparisons.